59th Annual Meeting of the Japanese Society of Neurology

Presentation information

Print

Luncheon Seminar

[LS-23] Takeda Pharmaceutical Company Limited.

MOA-B inhibitor, Rasagiline as a novel agent for treatment of Parkinson's disease

Fri. May 25, 2018 11:30 AM - 12:30 PM Room 2 (Sapporo Geibunkan / Zuisetsu （3F）)

Chair: Ryosuke Takahashi(Department of Neurology, Graduate School of Medicine, Kyoto University)

[LS-23-2] The role of MOA-B inhibitor, Rasagiline for the treatment of advanced Pakinson’s disease

○Atsushi Takeda (Department of Neurology, National Hospital Organization Sendai-Nishitaga Hospital)